These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 8496787

  • 1. Mutational analysis of the amino and carboxy termini of the HIV-2 Tat protein.
    Echetebu CO, Rice AP.
    J Acquir Immune Defic Syndr (1988); 1993 Jun; 6(6):550-7. PubMed ID: 8496787
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mutagenesis of EIAV TAT reveals structural features essential for transcriptional activation and TAR element recognition.
    Derse D, Newbold SH.
    Virology; 1993 Jun; 194(2):530-6. PubMed ID: 8389074
    [Abstract] [Full Text] [Related]

  • 6. Human immunodeficiency virus type 2 (HIV-2) trans-activator (Tat): functional domains and the search for trans-dominant negative mutants.
    Arya SK.
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):839-48. PubMed ID: 8257633
    [Abstract] [Full Text] [Related]

  • 7. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L, Morris GF, Lockyer JM, Lu M, Wang Z, Morris CB.
    Virology; 1997 Aug 18; 235(1):48-64. PubMed ID: 9300036
    [Abstract] [Full Text] [Related]

  • 8. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
    Pearson L, Garcia J, Wu F, Modesti N, Nelson J, Gaynor R.
    Proc Natl Acad Sci U S A; 1990 Jul 18; 87(13):5079-83. PubMed ID: 2195547
    [Abstract] [Full Text] [Related]

  • 9. Purification and functional characterization of wild-type and mutant HIV-1 and HIV-2 Tat proteins expressed in Escherichia coli.
    Orsini MJ, García-Martínez LF, Mavankal G, Gaynor RB, Debouck CM.
    Protein Expr Purif; 1996 Sep 18; 8(2):238-46. PubMed ID: 8812870
    [Abstract] [Full Text] [Related]

  • 10. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.
    Modesti N, Garcia J, Debouck C, Peterlin M, Gaynor R.
    New Biol; 1991 Aug 18; 3(8):759-68. PubMed ID: 1931822
    [Abstract] [Full Text] [Related]

  • 11. Function of exon 2 in optimal trans-activation by Tat of HIV type 2.
    Pagtakhan AS, Tong-Starksen SE.
    AIDS Res Hum Retroviruses; 1995 Nov 18; 11(11):1367-72. PubMed ID: 8573394
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structure and function of HIV-1 and SIV Tat proteins based on carboxy-terminal truncations, chimeric Tat constructs, and NMR modeling.
    Baier-Bitterlich G, Tretiakova A, Richardson MW, Khalili K, Jameson B, Rappaport J.
    Biomed Pharmacother; 1998 Nov 18; 52(10):421-30. PubMed ID: 9921410
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The basic RNA-binding domain of HIV-2 Tat contributes to preferential trans-activation of a TAR2-containing LTR.
    Chang YN, Jeang KT.
    Nucleic Acids Res; 1992 Oct 25; 20(20):5465-72. PubMed ID: 1437564
    [Abstract] [Full Text] [Related]

  • 18. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis.
    Kuppuswamy M, Subramanian T, Srinivasan A, Chinnadurai G.
    Nucleic Acids Res; 1989 May 11; 17(9):3551-61. PubMed ID: 2542902
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of Tat-mediated transactivation and HIV replication with Tat mutant and repressor domain fusion proteins.
    Fraisier C, Abraham DA, van Oijen M, Cunliffe V, Irvine A, Craig R, Dzierzak EA.
    Gene Ther; 1998 Jul 11; 5(7):946-54. PubMed ID: 9813666
    [Abstract] [Full Text] [Related]

  • 20. Heterologous basic domain substitutions in the HIV-1 Tat protein reveal an arginine-rich motif required for transactivation.
    Subramanian T, Govindarajan R, Chinnadurai G.
    EMBO J; 1991 Aug 11; 10(8):2311-8. PubMed ID: 2065667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.